Volume | 254,519 |
|
|||||
News | - | ||||||
Day High | 1.52 | Low High |
|||||
Day Low | 1.3607 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Hoth Therapeutics Inc | HOTH | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.40 | 1.3607 | 1.52 | 1.52 | 1.38 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
863 | 254,519 | $ 1.46 | $ 370,370 | - | 0.99 - 4.30 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:36:19 | formt | 407 | $ 1.47 | USD |
Hoth Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6.56M | 4.35M | - | 0 | -11.37M | -2.62 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Hoth Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOTH Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.37 | 1.65 | 1.30 | 1.43 | 875,120 | 0.10 | 7.30% |
1 Month | 1.27 | 1.67 | 1.15 | 1.37 | 1,270,157 | 0.20 | 15.75% |
3 Months | 1.45 | 1.69 | 1.15 | 1.36 | 513,621 | 0.02 | 1.38% |
6 Months | 1.54 | 1.73 | 0.99 | 1.40 | 355,922 | -0.07 | -4.55% |
1 Year | 2.18 | 4.30 | 0.99 | 2.64 | 696,350 | -0.71 | -32.57% |
3 Years | 51.75 | 55.00 | 0.99 | 22.45 | 1,439,409 | -50.28 | -97.16% |
5 Years | 128.75 | 226.75 | 0.99 | 34.92 | 1,227,549 | -127.28 | -98.86% |
Hoth Therapeutics Description
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups. |